NCT06893887
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- China Pharmaceutical University Affiliated Nanjing Tianyinshan Hospital Nanjing, Jiangsu, China
Clinical trial condition
Explore clinical trials studying Hepatocellular Carcinoma(HCC). Study availability and eligibility vary by location and protocol.
NCT06893887
NCT01642446